









Markets
/
Stocks
/
nasdaq-itgr
/

Integer Holdings Corp

ITGR

100.190USD

-1.150-1.13%

Close 09/15, 16:00（ET）Quotes delayed by 15 min

3.51BMarket Cap

42.46P/E TTM



Integer Holdings Corp

100.190

-1.150-1.13%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-15

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

35 / 207

Overall Ranking

137 / 4724

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 11 analysts

Buy

Current Rating

140.875

Target Price

+39.01%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. It operates through Medical segment, which includes the cardio and vascular; cardiac rhythm management and neuromodulation, and advanced surgical; orthopedics and portable medical product lines. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 28.94% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 80.63.

Overvalued

The company’s latest PE is 40.96, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 41.16M shares, decreasing 2.80% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 3.90M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.25.

Financial Health

Currency: USD Updated：2025-09-15

The company's current financial score is 6.86, which is lower than the Healthcare Equipment & Supplies industry's average of 7.15. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 437.39M, representing a year-over-year increase of 7.26%, while its net profit experienced a year-over-year increase of 209.65%.

Score

Industry at a Glance

Previous score

6.86

Change

0.39



Financials

4.40

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.71

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.63

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.48

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-15

The company’s current valuation score is 4.80, which is higher than the Healthcare Equipment & Supplies industry's average of 2.15. Its current P/E ratio is 44.18, which is -8.51% below the recent high of 40.42 and 16.10% above the recent low of 37.07.

Score

Industry at a Glance

Previous score

3.50

Change

0.04

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 35/207

No Data

Earnings Forecast

Currency: USD Updated：2025-09-15

The company’s current earnings forecast score is 8.18, which is higher than the Healthcare Equipment & Supplies industry's average of 7.66. The average price target for Integer Holdings Corp is 140.00, with a high of 155.00 and a low of 132.00.

Score

Industry at a Glance

Previous score

8.18

Change

Support & Resistance

No Data

Analyst Rating

Based on 11 analysts

Buy

Current Rating

140.875

Target Price

+39.01%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Integer Holdings Corp

ITGR

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-15

The company’s current price momentum score is 7.06, which is lower than the Healthcare Equipment & Supplies industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 111.01 and the support level at 105.15, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.47

Change

0.04

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.975

Sell

RSI(14)

32.018

Neutral

STOCH(KDJ)(9,3,3)

10.918

Oversold

ATR(14)

2.226

High Vlolatility

CCI(14)

-175.743

Sell

Williams %R

95.354

Oversold

TRIX(12,20)

-0.180

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

102.750

Sell

MA10

104.632

Sell

MA20

106.170

Sell

MA50

109.366

Sell

MA100

114.986

Sell

MA200

122.616

Sell

Institutional Confidence

Currency: USD Updated：2025-09-15

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. The latest institutional shareholding proportion is 117.48%, representing a quarter-over-quarter decrease of 1.84%. The largest institutional shareholder is The Vanguard, holding a total of 3.90M shares, representing 11.14% of shares outstanding, with 2.40% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

4.82M

-2.98%

The Vanguard Group, Inc.

Star Investors

3.77M

-1.58%

Invesco Advisers, Inc.

1.30M

+3.27%

Dimensional Fund Advisors, L.P.

1.54M

-9.52%

State Street Global Advisors (US)

1.31M

-3.07%

Viking Global Investors LP

Star Investors

1.18M

+1.87%

EARNEST Partners, LLC

1.14M

-1.85%

Geode Capital Management, L.L.C.

788.06K

+3.31%

Columbia Threadneedle Investments (UK)

836.99K

+3.40%

Risk Assessment

Currency: USD Updated：2025-09-15

The company's beta value is 1.03. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.